EGAPP logo

EGAPP logo

Evaluation of Genomic Applications in Practice and Prevention
Understanding EGAPP PDF icon Download PDF (460 KB)

Steps in the EGAPP Working Group Review Process

Overview   |   Step 1   |   Step 2   |   Step 3   |   Step 4

Step 3

Summary: The EGAPP Working Group (EWG) reviews the evidence report, considers contextual issues, and may consider other sources of evidence. A draft recommendation statement is developed, peer-reviewed, and submitted for publication.

EWG Recommendation Statements are based on CDC-commissioned evidence reports, other review of evidence as needed, the quality of available data, and potential clinical and social impact of using the test in practice.

Who is involved: EWG, with support from CDC-based EGAPP staff and consultants.

Transparency: Review of comments from industry and a range of stakeholders (e.g., from professional organizations, health plans, consumer groups, and public health programs).

Products:

  • Peer-reviewed, published EWG Recommendation Statements

 

Recommendation Statement Development Process

chart


>> See Step 4: Disseminate EGAPP Products & Communicate Informational Messages to Stakeholders

Page last updated: December 23, 2008
Page last reviewed: December 23, 2008
Content Source: EGAPP Team